startup.bid
EN
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

Spect

Value-based retinal screening in primary care to prevent blindness.

Shut down

About

Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.

Topics

Digital HealthAIHealthcareConsumer Health and Wellness
Location
San Francisco, CA, United States
Team size
7 employees
YC batch
Summer 2017
Status
Shut down
Stage
Early stage

Similar startups & competitors

Questions and answers

What does Spect do?

Value-based retinal screening in primary care to prevent blindness.

Where is Spect based?

San Francisco, CA, United States

How many people work at Spect?

7 employees, according to the company profile.

Has Spect raised money?

There are no funding rounds for Spect in our data.

What are the alternatives to Spect?

Similar startups: Microhealth, Sonia, and RTHM.